Thus, TSA treatment was shown to cause genomic hypomethylation as a result of decreased nuclear DNMT1 levels [44] in T24 cells (bladder carcinoma) and also in MDA-MB-231 cells (breast carcinoma) [40]. The gene discussed is DNMT1; the disease is breast carcinoma.